New Market Report Now Available: Courtagen Life Sciences, Inc. - Product Pipeline Analysis, 2013 Update
Courtagen Life Sciences, Inc. (Courtagen) is a health care service provider. The company offers genomic and proteomic products and services for the treatment of neurological and metabolic disorders. Its product consists of POC protein biomarker technologies such as Avantra Q400 biomarker workstation and QPDx biochip. Courtagen's service portfolio comprises genetic testing services that include mtSEEK, a whole mitochondrial genome analysis; nucSEEK, a comprehensive sequence analysis of nuclear mitochondrial exome; epiSEEK, a comprehensive next-generation sequencing analysis for epileptic disorders; and protein...
View full press release